About Sema4 Holdings
Sema4 Holdings Corp, formerly CM Life Sciences Inc., is a patient-centered health intelligence company, which is focused on advancing healthcare through data-driven insights. The Company applies artificial intelligence (AI) and machine learning to clinical and genomic data to build models of human health and defining individualized health trajectories. The Company’s health intelligence platform, Centrellis enables users to generate complete understanding of disease and wellness and to provide science-driven solutions to the pressing medical needs. Its products include Noninvasive Prenatal Select, Expanded Carrier Screen, Natalis Newborn Screen and Sema4 Signal Oncology Solutions. Noninvasive Prenatal Select is a blood test for insight into the user’s baby health from nine weeks into pregnancy. Expanded Carrier Screen is a carrier screen for inherited conditions. Natalis Newborn Screen is a home test that provides insight into user’s baby health by screening childhood diseases.